Sigma-Aldrich Posts 5 Percent Revenue Growth for Q4 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its fourth-quarter revenues increased 5 percent, or 3 percent organically, but it fell short of Wall Street's expectations.

The St. Louis-based research and chemical products firm reported total revenues of $610 million for the three-month period ended Dec. 31, compared to $582 million for the fourth quarter of 2010. Analysts, on average, had expected revenues of $626.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.